Properties of Mucoid Serotype 3 Streptococcus pneumoniae From Children in China

Ying Yang1,2, Chun-Zhen Hua1, Chao Fang3

  • 1Department of Infectious Diseases, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou, China.

Abstract

Insights

Mucoid serotype 3 Streptococcus pneumoniae in Chinese children causes noninvasive infections. These strains show high susceptibility to many antibiotics but resistance to erythromycin, with CC505 being a novel genotype.

Area of Science:

  • Microbiology
  • Epidemiology
  • Genetics

Background:

  • Streptococcus pneumoniae (S. pneumoniae) is a significant pathogen, with specific serotypes and phenotypes influencing disease presentation and treatment.
  • Mucoid variants of S. pneumoniae, particularly serotype 3, have been less characterized, especially in pediatric populations in China.

Purpose of the Study:

  • To investigate the characteristics of hosts, antimicrobial susceptibility, and molecular epidemiology of mucoid serotype 3 S. pneumoniae in Chinese children.

Main Methods:

  • Analysis of S. pneumoniae isolates (2016-2019) with mucoid phenotype and serotype 3 confirmation.
  • Antimicrobial susceptibility testing using E-test and molecular typing via multilocus sequence typing (MLST).

Main Results:

  • Twenty mucoid serotype 3 S. pneumoniae isolates were identified, all from noninvasive infections in children (mean age 5.69 years).
  • Isolates were commonly found in respiratory samples (tonsils, adenoids, sputum) and showed susceptibility to most tested antibiotics except erythromycin.
  • Sequence type (ST)505 and its clonal complex (CC505) were predominant (95%), with CC505 exhibiting higher MICs for tetracycline, trimethoprim/sulfamethoxazole, and meropenem compared to ST180.

Conclusions:

  • Mucoid serotype 3 S. pneumoniae causes noninvasive infections in children, primarily affecting the respiratory system.
  • These isolates demonstrate broad antibiotic susceptibility, particularly to beta-lactams, but resistance to macrolides.
  • CC505 represents a novel clonal complex in China with distinct characteristics, potentially related to the global CC180.